Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site

Background/Purpose. We aimed to investigate the influence of the sampling site on the variability of ACT measurement. Activated clotting time (ACT) has been used for decades in cardiac surgery and interventional cardiology to assess unfractionated heparin activity. However, standardized protocols fo...

Full description

Saved in:
Bibliographic Details
Main Authors: J. C Heemelaar, T. Berkhout, A. A. C. M. Heestermans, J. C. Zant, A. M. J. de Vos, N. J. W. Verouden, M. T. Dirksen, J. van Ramshorst
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Interventional Cardiology
Online Access:http://dx.doi.org/10.1155/2021/4091289
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566301218832384
author J. C Heemelaar
T. Berkhout
A. A. C. M. Heestermans
J. C. Zant
A. M. J. de Vos
N. J. W. Verouden
M. T. Dirksen
J. van Ramshorst
author_facet J. C Heemelaar
T. Berkhout
A. A. C. M. Heestermans
J. C. Zant
A. M. J. de Vos
N. J. W. Verouden
M. T. Dirksen
J. van Ramshorst
author_sort J. C Heemelaar
collection DOAJ
description Background/Purpose. We aimed to investigate the influence of the sampling site on the variability of ACT measurement. Activated clotting time (ACT) has been used for decades in cardiac surgery and interventional cardiology to assess unfractionated heparin activity. However, standardized protocols for the use of ACT measurement in the catheterization laboratory are lacking. Methods/Materials. After elective cardiac catheterization, ACT measurements were collected in simultaneously obtained blood samples from three different sample sites: the arterial catheter, arterial sheath, and peripheral intravenous line. Measurements were performed using the i-Stat® device (Abbott, Princeton, NJ, USA). The study was conducted with approval of the local medical ethical committee. Results. In 100 patients (mean age 67.1, 65% male), no significant differences were observed in ACT values obtained from the guiding catheter and arterial sheath (mean difference (MD) −18.3 s; standard deviation (SD) 96 s; P=0.067). Contrarily, ACT values obtained from the intravenous line were significantly lower as compared to values obtained from the guiding catheter (MD 25.7 s; SD 75.5; P=0.003) and arterial sheath (MD 39 s; SD 102.8; P<0.001). Furthermore, ACT measurements from the arterial sheath showed a statistically significant proportional bias when compared to the other sampling sites (sheath vs. catheter, r = 0.761, P=0.001; sheath vs. IVL, r = 1.013, P<0.001). Conclusions. The present study shows statistical significance and possibly clinically relevant variations between ACT measurements from different sample sites. Bias in ACT measurements may be minimized by using uniform protocols for ACT measurement during cardiac catheterization.
format Article
id doaj-art-ca59be4459bf45b89c9b7f036fd9a7be
institution Kabale University
issn 0896-4327
1540-8183
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Interventional Cardiology
spelling doaj-art-ca59be4459bf45b89c9b7f036fd9a7be2025-02-03T01:04:33ZengWileyJournal of Interventional Cardiology0896-43271540-81832021-01-01202110.1155/2021/40912894091289Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling SiteJ. C Heemelaar0T. Berkhout1A. A. C. M. Heestermans2J. C. Zant3A. M. J. de Vos4N. J. W. Verouden5M. T. Dirksen6J. van Ramshorst7Department of Cardiology, Northwest Clinics, Alkmaar, NetherlandsDepartment of Cardiology, Northwest Clinics, Alkmaar, NetherlandsDepartment of Cardiology, Northwest Clinics, Alkmaar, NetherlandsDepartment of Clinical Chemistry, Northwest Clinics, Alkmaar, NetherlandsDepartment of Cardiology, Catharina Hospital, Eindhoven, NetherlandsDepartment of Cardiology, Amsterdam University Medical Center, Amsterdam, NetherlandsDepartment of Cardiology, Northwest Clinics, Alkmaar, NetherlandsDepartment of Cardiology, Northwest Clinics, Alkmaar, NetherlandsBackground/Purpose. We aimed to investigate the influence of the sampling site on the variability of ACT measurement. Activated clotting time (ACT) has been used for decades in cardiac surgery and interventional cardiology to assess unfractionated heparin activity. However, standardized protocols for the use of ACT measurement in the catheterization laboratory are lacking. Methods/Materials. After elective cardiac catheterization, ACT measurements were collected in simultaneously obtained blood samples from three different sample sites: the arterial catheter, arterial sheath, and peripheral intravenous line. Measurements were performed using the i-Stat® device (Abbott, Princeton, NJ, USA). The study was conducted with approval of the local medical ethical committee. Results. In 100 patients (mean age 67.1, 65% male), no significant differences were observed in ACT values obtained from the guiding catheter and arterial sheath (mean difference (MD) −18.3 s; standard deviation (SD) 96 s; P=0.067). Contrarily, ACT values obtained from the intravenous line were significantly lower as compared to values obtained from the guiding catheter (MD 25.7 s; SD 75.5; P=0.003) and arterial sheath (MD 39 s; SD 102.8; P<0.001). Furthermore, ACT measurements from the arterial sheath showed a statistically significant proportional bias when compared to the other sampling sites (sheath vs. catheter, r = 0.761, P=0.001; sheath vs. IVL, r = 1.013, P<0.001). Conclusions. The present study shows statistical significance and possibly clinically relevant variations between ACT measurements from different sample sites. Bias in ACT measurements may be minimized by using uniform protocols for ACT measurement during cardiac catheterization.http://dx.doi.org/10.1155/2021/4091289
spellingShingle J. C Heemelaar
T. Berkhout
A. A. C. M. Heestermans
J. C. Zant
A. M. J. de Vos
N. J. W. Verouden
M. T. Dirksen
J. van Ramshorst
Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
Journal of Interventional Cardiology
title Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
title_full Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
title_fullStr Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
title_full_unstemmed Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
title_short Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
title_sort measuring activated clotting time during cardiac catheterization and pci the effect of the sampling site
url http://dx.doi.org/10.1155/2021/4091289
work_keys_str_mv AT jcheemelaar measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT tberkhout measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT aacmheestermans measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT jczant measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT amjdevos measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT njwverouden measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT mtdirksen measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite
AT jvanramshorst measuringactivatedclottingtimeduringcardiaccatheterizationandpcitheeffectofthesamplingsite